Captrust Financial Advisors Castle Biosciences Inc Transaction History

Captrust Financial Advisors

  • $33 Billion
  • Q3 2024

A detailed history of Captrust Financial Advisors transactions in Castle Biosciences Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 8,072 shares of CSTL stock, worth $223,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,072
Previous 21,125 61.79%
Holding current value
$223,675
Previous $459,000 49.89%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$17.4 - $31.47 $227,122 - $410,777
-13,053 Reduced 61.79%
8,072 $230,000
Q2 2024

Aug 14, 2024
BUY
$18.84 - $24.94 $1,413 - $1,870
75 Added 0.36%
21,125 $459,000
Q1 2024

May 15, 2024
SELL
$18.06 - $25.3 $313,503 - $439,182
-17,359 Reduced 45.2%
21,050 $466,000
Q4 2023

Feb 14, 2024
SELL
$12.19 - $22.43 $3,949 - $7,267
-324 Reduced 0.84%
38,409 $828,000
Q3 2023

Nov 14, 2023
SELL
$13.28 - $20.3 $2.54 Million - $3.88 Million
-190,958 Reduced 83.14%
38,733 $654,000
Q2 2023

Aug 14, 2023
BUY
$11.66 - $26.0 $710,781 - $1.58 Million
60,959 Added 36.13%
229,691 $3.15 Million
Q1 2023

May 15, 2023
BUY
$19.47 - $28.49 $3.29 Million - $4.81 Million
168,732 New
168,732 $3.83 Million
Q2 2022

Aug 23, 2022
SELL
$16.0 - $45.99 $56,336 - $161,930
-3,521 Reduced 87.63%
497 $11,000
Q2 2022

Aug 16, 2022
BUY
$16.0 - $45.99 $56,832 - $163,356
3,552 Added 762.23%
4,018 $88,000
Q1 2022

May 16, 2022
BUY
$33.17 - $46.98 $1,127 - $1,597
34 Added 7.87%
466 $21,000
Q4 2021

Feb 14, 2022
SELL
$39.06 - $67.58 $2,617 - $4,527
-67 Reduced 13.43%
432 $19,000
Q3 2021

Nov 16, 2021
BUY
$60.13 - $77.6 $3,908 - $5,044
65 Added 14.98%
499 $33,000
Q2 2021

Aug 16, 2021
BUY
$50.07 - $76.78 $19,477 - $29,867
389 Added 864.44%
434 $32,000
Q1 2021

May 17, 2021
BUY
$58.92 - $97.33 $2,651 - $4,379
45 New
45 $3,000

Others Institutions Holding CSTL

# of Institutions
204
Shares Held
26M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $729M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email